HOME Top Market Reports Mice Model Market - by Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care Products [Cages, Bedding, Feed] - Forecasts to 2018

Mice Model Market - by Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care Products [Cages, Bedding, Feed] - Forecasts to 2018

By: marketsandmarkets.com
Publishing Date: January 2014
Report Code: BT 2192

 

  Speak to Analyst Enquiry Before Buying
 
purchase report
download pdf  request for customisation


The global mice model market is segmented on the basis of type, technology, disease, and mice model services. By type, the market comprises of inbred, outbred, knockout, conditioned/surgically modified, hybrid/congenic, and spontaneous mutant mice.

The market for mice model services is segmented into breeding, cryopreservation, quarantine, rederivation, genetic testing, model in-licensing, and other services (surgical and line rescue). Based on geography, the market is divided into North America, Europe, Asia, and the Rest of the World (RoW).

The biggest factor that is likely to drive the growth of this market is the ongoing innovations in the development of mice models. In addition, another factor that is likely to drive the growth of the market is the continuous research that is undertaken to develop treatments for fatal diseases such as cancer and HIV/AIDS. Furthermore, research institutes and government bodies have extended their help in the form of investments, funds, and grants, which have stimulated research activities to develop mice models. In addition, the demand for personalized medicines is expected to boost the use of humanized mice models.

A number of factors such as advancements in the biotechnology and biopharmaceutical industries as well as the increase in the number of R&D activities in pharmaceutical industries are propelling the growth of the mice model market. However, stringent regulations and laws for ethical use of animals in research are hindering the growth of this market. In addition, the market is facing a threat from advances in zebrafish models and rat models, which are leading to their increased use in research activities.

North America is the largest market for mice models, followed by Europe and Asia. Furthermore, the Asian and North American markets for mice models are expected to witness a healthy growth over the next five years.

The major players in the market include Charles River Laboratories (U.S.), The Jackson Laboratory (U.S.), Taconic farms, Inc. (U.S.), genOway S.A. (France), Covance, Inc. (U.S.), Crescendo Biologics Limited (U.K.), Deltagen, Inc. (U.S.), Harbour Antibodies BV (The Netherlands), Harlan Laboratories, Inc. (U.S.), TransGenic, Inc. (U.S.), SAGE Labs (U.S.), inGenious Targeting Laboratory, Inc. (U.S.), Lexicon Pharmaceuticals, ImmunoGenes AG (Switzerland), Mirimus, Inc. (U.S.), and Ablexis LLC (U.S.).

Scope of the Report

This research report categorizes the global mice model market into the following segments and sub-segments:

By Type

  • Inbred Mice
  • Outbred Mice
  • Conditioned/Surgically Modified Mice
  • Hybrid/Congenic Mice
  • Knockout Mice
  • Spontaneous Mutant Mice

By Technology

  • Microinjection
  • Embryonic Stem Cell Injection
  • Virus/Vector Mediated Gene Transfer
  • Nuclear transfer Technology
  • Genetically Modified Sperm
  • Others

By Disease

  • Oncology
  • Immunology & Inflammation
  • Central Nervous System
  • Cardiovascular
  • Diabetes
  • Metabolism & Regulation
  • Others

By Service

  • Breeding
  • Cryopreservation
  • Quarantine
  • Rederivation
  • Genetic Testing
  • Model In-licensing
  • Other Services (Surgical and Line Rescue)

By Geography

  • North America
  • Europe
  • Asia
  • RoW

Mice Care Products Market, by Segment

  • Bedding
  • Feed
  • Cages
  • Others

Table Of Contents                
                                 
                  
1 Introduction (Page No. - 35)                
  1.1 Markets Covered               
  1.2 Stakeholders                
  1.3 Research Methodology               
                  
2 Executive Summary  (Page No. - 51)              
                  
3 Market Dynamics  (Page No. - 60)              
  3.1 Drivers                
      3.1.1 Ongoing Innovations in Mice Models            
      3.1.2 Investments and Grants              
      3.1.3 Personalized Medicine to Fuel The Demand For Personalized Humanized Mice Models      
      3.1.4 Associations Propelling The Development of Embryonic Stem Cells (Es Cells) As Well As Knockout and Mutant Mice
      3.1.5 Global Conferences and Meetings Stimulate Market Growth          
      3.1.6 Genetic Similarity of Mice to Humans           
      3.1.7 Advancements in Biotechnology and Biopharmaceutical Industries           
      3.1.8 Increase in R&D Activities in Pharmaceutical Industries          
  3.2 Threats                
      3.2.1 Advances in Zebrafish Model Development            
      3.2.2 Increased Usage of Rat Models            
      3.2.3 Increased Benefits From Cryopreservation Is Likely to Hamper The Demand For Mice Models    
      3.2.4 Alternative Methods to Animal Testing            
      3.3 Barriers                
      3.3.1 Regulations and Laws For Ethical Use of Animals in Research       
  3.4 Opportunities                
      3.4.1 Upsurge in Research Involving Humanized Mice           
      3.4.2 Increase In Monoclonal Antibody Production            
  3.5 Challenges                
      3.5.1 Need For Improved Mice Models            
                  
4 Market Share Analysis, By Key Players (Page No. - 76)         
                  
5 Mice Model Market Size  (Page No. - 89)              
  5.1 Market By Type            
      5.1.1 Introduction                
      5.1.2 Inbred Mice               
      5.1.3 Outbred Mice               
      5.1.4 Hybrid/Congenic Mice               
      5.1.5 Spontaneous/Mutant Mice               
      5.1.6 Knockout Mice               
      5.1.7 Conditioned/Surgically Modified               
  5.2 Market By Technology            
      5.2.1 Introduction                
      5.2.2 Micro-Injection                
      5.2.3 Embryonic Stem Cell Injection             
      5.2.4 Nuclear Transferase Technology              
      5.2.5 Viruses/Vectors                
      5.2.6 Genetically Modified Sperms              
      5.2.7 Others                
  5.3 Market By Disease            
      5.3.1 Introduction                
      5.3.2 Oncology                
      5.3.3 Immunology and Inflammation              
      5.3.4 Diabetes                
      5.3.5 Cardiovascular                
      5.3.6 Central Nervous System              
      5.3.7 Metabolism and Regulation              
      5.3.8 Others                
  5.4 Market By Service            
      5.4.1 Introduction                
      5.4.2 Breeding                
      5.4.3 Cryopreservation                
      5.4.4 Quarantine                
      5.4.5 Rederivation                
      5.4.6 Genetic Testing               
      5.4.7 Model in Licensing              
      5.4.8 Others                
  5.5 Mice Care Products Market, By Segment           
      5.5.1 Introduction                
      5.5.2 Cages                
      5.5.3 Bedding                
      5.5.4 Feed                
      5.5.5 Others                
                  
6 Geographic Analysis (Page No. - 148)               
  6.1 Introduction                
  6.2 North America               
      6.2.1 Investments in The Development of Mice Models to Increase Their Application Areas     
      6.2.2 Growing Biomedical Research in The U.S.to Boost The Market        
      6.2.3 Preclinical Activities By Cros and Pharmaceutical R&D to Propel The Market      
      6.2.4 Growth in Rare Diseases to Create Demand For Mice Models       
      6.2.5 Mexico- Production Hub For Global Pharmaceutical Companies          
  6.3 Europe                
      6.3.1 Need For Better Mice Models to Trigger Investments and Innovation       
      6.3.2 Growth in Biosimilars Market Calls For Increased Preclinical Activities        
      6.3.3 Events Conducted By Animal Care Associations to Promote The Ethical Use of Mice    
      6.3.4 Increase in Tailored Mice Models For Cancer and Rare Disease Projects      
  6.4 Asia                
      6.4.1 Less Stringent Laws Creates A Potential For Outsourcing of Animal Models and Services    
      6.4.2 Growth in Translational Research in Singapore to Fuel The Market       
      6.4.3 Increasing R&D Activities Provide Impetus to Preclinical Research         
      6.4.4 Mandatory Animal Testing For All Pharmaceutical Drugs and Cosmetics in China      
      6.4.5 Growth in Regenerative Medicine, Biomedical, and Medical Research in Japan       
      6.4.6 Increase in Neuroscience Research in Malaysia           
      6.4.7 Government-Supported Strong Academic and Commercial R&D Activities in Taiwan        
      6.4.8 Rising Pharmaceutical and Biotechnology R&D Activities in Korea         
  6.5 ROW                
      6.5.1 Pharmaceutical, Biotechnology, and Research industries in Brazil to Bolster The Market      
      6.5.2 Ongoing Biomedical Research Activities in Australia and New Zealand to Strengthen The Market    
      6.5.3 Favorable Business Environment For Pharmaceutical and Biotechnology industries in Saudi Arabia and Uae    
                  
7 Competitive Landscape (Page No. - 207)                
  7.1 Competitive Developments Mapping              
  7.2 Agreements, Partnerships, Collaborations, and Joint Ventures           
  7.3 Licensing                
  7.4 Grants and Funds              
  7.5 Marketing and Promotion              
  7.6 Expansions                
  7.7 Patents                
  7.8 Others                
                  
8 Company Profiles (Page No. - 245)                
  8.1 Ablexis, LLC               
  8.2 Charles River Laboratories, Inc.             
  8.3 Covance, Inc.               
  8.4 Crescendo Biologics,               
  8.5 Deltagen, Inc.               
  8.6 Genoway Sa               
  8.7 Harbour Antibodies Bv              
  8.8 Harlan Laboratories, Inc.              
  8.9 Immunogenes Ag               
  8.1 Ingenious Targeting Laboratory              
  8.11 Lexicon Pharmaceuticals, Inc.              
  8.12 Mirimus, Inc.               
  8.13 Taconic Farms, Inc.              
  8.14 The Jackson Laboratory              
  8.15 Transgenic, Inc.               
  8.16 Sage Labs               
                  
9 Preclinical Pipeline (Page No. - 299)                
                  
10 Industry Speaks (Page No. - 314)                
                  
11 Cost Assessment and Mouse Model Outlicensing/Buyer Companies Assessment (Page No. - 230)          
  11.1 Cost of Maintaining A Transgenic Mouse Colony          
  11.2 List of Mouse Model Outlicensing/Buyer Companies           


List Of Tables (116 Tables)                

Table 1 Primary Research Sampling Frame          
Table 2 Global Mice Model and Mice Care Products Market, 2013- 2018 ($Million)     
Table 3 Global Mice Model Market, By Geography, 2013-2018 ($Million)       
Table 4 Global Market By Type, 2013 2018 ($Million)      
Table 5 Inbred Market, By Geography, 2013 2018 ($Million)      
Table 6 Knockout Mice Model Market, By Geography, 2013 2018 ($Million)      
Table 7 Outbred Mice Model Market, By Geography, 2013 2018 ($Million)      
Table 8 Hybrid/Congenic Mice Model Market, By Geography, 2013 2018 ($Million)      
Table 9 Spontenous Mutant Mice Model Market, By Geography, 2013 2018 ($Million)     
Table 10 Conditioned/Surgically Modified Mice Model Market, By Geography, 2013 2018 ($Million)     
Table 11 Global Market, By Technology, 2013 2018 ($Million)    
Table 12 Microinjection Based Mice Model Market, By Geography, 2013 2018 ($Million)     
Table 13 Embryonic Stem Cell Injection Based Mice Model Market, By Geography, 2013 2018 ($Million)  
Table 14 Virus/Vector-Mediated Gene Transfer Based Mice Model Market, By Geography, 2013 2018 ($Million)   
Table 15 Nuclear Transfer Technology Based Mice Model Market, By Geography, 2013 2018 ($Million)   
Table 16 Genetically Modified Sperm Based Mice Model Market, By Geography, 2013 2018 ($Million)   
Table 17 Other Technology Based Mice Model Market, By Geography, 2013 2018 ($Million)    
Table 18 Global Market, By Disease, 2013 2018 ($Million)      
Table 19 Oncology Mice Model Market, By Geography, 2013 2018 ($Million)      
Table 20 Immunology & Inflammation Mice Model Market, By Geography, 2013 2018 ($Million)    
Table 21 Central Nervous System Mice Model Market, By Geography, 2013 2018 ($Million)    
Table 22 Cardiovascular Mice Model Market, By Geography, 2013 2018 ($Million)      
Table 23 Diabetes Mice Model Market, By Geography, 2013 2018 ($Million)      
Table 24 Metabolism & Regulation Mice Model Market, By Geography, 2013 2018 ($Million)    
Table 25 Other Diseases Mice Model Market, By Geography, 2013 2018 ($Million)     
Table 26 Global Market, By Service, 2013 2018 ($Million)      
Table 27 Global Market By Type, By Geography, 2013 2018 ($Million)    
Table 28 Breeding Services Market, By Geography, 2013 2018 ($Million)       
Table 29 Cyropreservationservices Market, By Geography, 2013 2018 ($Million) 130       
Table 30 Quarantine Services Market, By Geography, 2013 2018 ($Million)       
Table 31 Rederivation Services Market, By Geography, 2013 2018 ($Million)       
Table 32 Genetic Testingservices Market, By Geography, 2013 2018 ($Million)       
Table 33 Model in-Licensingservices Market, By Geography, 2013 2018 ($Million)       
Table 34 Otherservices Market, By Geography, 2013 2018 ($Million)        
Table 35 Global Mice Care Products Market By Segment, 2013 2018 ($Million)     
Table 36 Global Mice Care Products Market, By Geography, 2013 2018 ($Million)     
Table 37 Global Venture Financing For Preclinical Activities in U.S.        
Table 38 Innovation Centers Set Up in U.S.         
Table 39 Collaborations For Preclinical Activities in The Year 2013 For U.S. Based Companies    
Table 40 Grants and Contracts For Preclinical Activities in U.S.        
Table 41 Cages Market, By Geography, 2013 2018 ($Million)        
Table 42 Bedding Market, By Geography, 2013 2018 ($Million)        
Table 43 Feed Market, By Geography, 2013 2018 ($Million)        
Table 44 Other Care Products Market, By Geography, 2013 2018 ($Million)      
Table 45 Global Mice Model Market, $Million (2013 -2018)         
Table 46 Nih Funding For Projects Related to Animal Models        
Table 47 Associations Directly Related to The Animal Model Market With Event Dates     
Table 48 Associations indirectly Related to The Animal Model Market With Event Dates     
Table 49 Distribution of Products and Projects By Phase (December 2011)       
Table 50 North America : Mice Model Market, $Million (2013 -2018)       
Table 51 North America : Market, By Type, $Million (2013 -2018)     
Table 52 North America : Market, By Technology, $Million (2013 -2018)     
Table 53 North America : Market, By Disease, $Million (2013 -2018)     
Table 54 North America : Market, By Service, $Million (2013 -2018)     
Table 55 North America : Mice Care Products Market, By Segment, $Million (2013 -2018)    
Table 56 Biosimilars Pipeline - European Region -2011          
Table 57 Biosimilars Under Review By Ema -2013          
Table 58 Events Conducted By Animal Care Associations to Promote The Ethical Use of Mice   
Table 59 EU-Funded Projects For Rare Diseases That Made Use of Mice Models     
Table 60 Europe: Mice Model Market, $Million (2013 -2018)         
Table 61 Europe: Market, By Type, $Million (2013 -2018)       
Table 62 Europe: Market, By Technology, $Million (2013 -2018)       
Table 63 Europe: Market, By Disease, $Million (2013 -2018)       
Table 64 Europe: Market, By Service, $Million (2013 -2018)       
Table 65 Europe: Mice Care Products Market, By Segment, $Million (2013 -2018)      
Table 66 AAALAC - Accredited Companies/institutes/Organizations/Universities, By Geography           
Table 67 Number of Guidelines/Associations For Regulatory Care of Animals, By Geography      
Table 68 Significant Funding Activities in Translational Research in Singapore        
Table 69 Global Researcher Views of Leading Countries in R&D By Research/Technology Area     
Table 70 R & D Trend in india            
Table 71 Research Partnerships With Japan            
Table 72 Research Projects Conducted At The Universiti Putra Malaysia        
Table 73 Asia: Mice Model Market, $Million (2013 -2018)         
Table 74 Asia: Market, By Type, $Million (2013 -2018)       
Table 75 Asia: Market, By Technology, $Million (2013 -2018)       
Table 76 Asia: Market, By Disease, $Million (2013 -2018)       
Table 77 Asia: Market, By Service, $Million (2013 -2018)       
Table 78 Asia: Mice Care Products Market, By Segment, $Million (2013 -2018)      
Table 79 List of institutes Partnered Or Affiliated With The Australian Phenomics Network     
Table 80 ROW: Mice Model Market, $Million (2013 -2018)         
Table 81 ROW: Market, By Type, $Million (2013 -2018)       
Table 82 ROW: Market, By Technology, $Million (2013 -2018)       
Table 83 ROW: Market, By Disease, $Million (2013 -2018)       
Table 84 ROW: Market, By Service, $Million (2013 -2018)       
Table 85 ROW: Mice Care Products Market, By Segment, $Million (2013 -2018)      
Table 86 Agreements, Partnerships, Collaborations, and Joint Ventures (2010 2013)       
Table 87 Licensing (20102013)              
Table 88 Grants and Funds (2010 2013)          
Table 89 Marketing and Promotion (2010 2013)          
Table 90 Expansions (2010 2013)            
Table 91 Patents (2010 2013)            
Table 92 New Product Launches (2010 2013)          
Table 93 Others (2010 2013)            
Table 94 Charles River Laboratories, Inc.: Products           
Table 95 Charles River Laboratories, Inc.: Services           
Table 96 Covance, Inc.: Services             
Table 97 Covance, Inc.: Strategy             
Table 98 Genoway S.A.: Products             
Table 99 Genoway S.A.: Services             
Table 100 Genoway S.A.: Technologies For Creating Mice Models         
Table 101 Harlan Laboratories, Inc. : Products           
Table 102 Harlan Laboratories, Inc. : Services           
Table 103 Harlan Laboratories, Inc. : Mice Care Products         
Table 104 Sage Labs : Products            
Table 105 Sage Labs : Services            
Table 106 Taconic Farms : Products            
Table 107 Taconic Farms : Services            
Table 108 The Jackson Laboratory : Products           
Table 109 The Jackson Laboratory : Services           
Table 110 Transgenic, Inc. : Products            
Table 111 Transgenic, Inc. : Services            
Table 112 List of Companies With Preclinical Pipeline (2010 2013)       
Table 113 Cost of Maintaining A Transgenic Mouse Colony         
Table 114 Cost of Production of Transgenic Mice          
Table 115 Cost of Sevices For Transgenic Mice          
Table 116 List of Mice Model Out Licensing and Buyer Companies       

                
List Of Figures (85 Figures)                
            
Figure 1 Market Segmentation           
Figure 2 Key Stakeholders              
Figure 3 Research Methodology- Market Size Estimation           
Figure 4 Research Methodology- Market Sizing            
Figure 5 Research Methodology- Competitive Assessment            
Figure 6 Research Methodology- Data Triangulation            
Figure 7 Research Methodology- Secondary Research Procedure           
Figure 8 Global Mice Model Market, By Type, 2013 ($Million)        
Figure 9 Global Market, By Services, 2013 ($Million)        
Figure 10 Global Market, By Geography, 2013 ($Million)        
Figure 11 Market Share, By Company (in Terms of $Value), 2013       
Figure 12 Competitive Positioning, By Company (2010 2013)         
Figure 13 Mice Model Market (Inclusive of Models and Services, Based On Value, 2012)    
Figure 14 Mice Model Market Segmentation, By Type          
Figure 15 Inbred and Knockout Mice Model Market, $Million (2013 2018)      
Figure 16 Mice Model Market Segmentation, By Technology 103         
Figure 17 Microinjection and Embryonic Stem Cell Based Mice Model Market, $Million (2013 2018)   
Figure 18 Mice Model Market, By Disease           
Figure 19 Oncology and Immunology and Inflammation Mice Model Market, 2013 2018 ($Million)    
Figure 20 Mice Model Market Segmentation, By Service          
Figure 21 Inbred and Knockout Mice Model Market, $Million (2013 - 2018)      
Figure 22 Comparison of Global Mice Model Market By Services, By Geography (For The Year 2013 and 2018)
Figure 23 Mice Care Products Market, By Segment          
Figure 24 Cages and Feed Market, $Million (2013 - 2018)        
Figure 25 Comparison of Global Mice Care Products Market, By Geography (For The Year 2013 and 2018) 
Figure 26 Tapped/Matured and Untapped/Potential Markets            
Figure 27 Mice Model Market, By Geography           
Figure 28 Mice Model Market Geographic Analysis           
Figure 29 Scientific R&D Spending, By Country           
Figure 30 Competitive Developments Mapping (top Five Players For Each Key Growth Strategy)     
Figure 31 Share of Key Strategies (2010 2013         
Figure 32 Most Active Companies (2010 2013)          
Figure 33 Share of Agreements, Partnerships, Collaborations, and Joint Ventures (2010 2013)      
Figure 34 Share of Licensing (20102013)            
Figure 35 Share of Grants and Funds (2010 2013)        
Figure 36 Share of Marketing and Promotion (2010 2013)        
Figure 37 Share of Expansions (2010 2013)          
Figure 38 Share of Patents (2010 2013)          
Figure 39 Share of New Product Launches (2010 2013)        
Figure 40 Share of Others (2010 2013)          
Figure 41 Ablexis Llc : Geographic Presence           
Figure 42 Ablexis Llc : Strategy            
Figure 43 Charles River Laboratories, Inc.: Geographic Presence          
Figure 44 Charles River Laboratories, Inc.: total Revenue, 2010 2012 ($Million )     
Figure 45 Charles River Laboratories, Inc.: total Revenue, By Segment, 2010 2012 ($Million )   
Figure 46 Charles River Laboratories, Inc.: Total Revenue, By Geography, 2010 2012 ($Million )   
Figure 47 Covance, Inc.: Geographic Presence            
Figure 48 Covance, Inc.: Total Revenue, 2010 2012 ($Million )       
Figure 49 Covance, Inc.: Total Revenue, By Segment, 2010 2012 ($Million )     
Figure 50 Covance, Inc.: Total Revenue, By Geography, 2010 2012 ($Million )     
Figure 51 Crescendo Biologics: Geographic Presence            
Figure 52 Crescendo Biologics: Strategy              
Figure 53 Deltage N, Inc.: Geographic Presence           
Figure 54 Deltagen, Inc.: Total Revenue, 2010 2012 ($Million )       
Figure 55 Deltage N, Inc.: Strategy            
Figure 56 Genoway S.A.: Geographic Presence            
Figure 57 Genoway S.A.: Total Revenue, 2010 2012 ($Million )       
Figure 58 Genoway S.A.: Total Revenue, By Geography, 2010 2012 ($Million )     
Figure 59 Genoway S.A.: Strategy              
Figure 60 Harbour Antibodies Bv : Geographic Presence          
Figure 61 Harbour Antibodies Bv : Strategy           
Figure 62 Harlan Laboratories, Inc. : Geographic Presence          
Figure 63 Harlan Laboratories, Inc. : Strategy           
Figure 64 Immunogenes Ag : Geographic Presence           
Figure 65 Immunogenes Ag : Strategy            
Figure 66 Ingenious Targeting Laboratory : Geographic Presence          
Figure 67 Ingenious Targeting Laboratory : Stratgey           
Figure 68 Lexicon Pharmaceuticals : Geographic Presence           
Figure 69 Lexicon Pharmaceuticals : Total Revenue, 2010 2012 ($Million )      
Figure 70 Lexicon Pharmaceuticals : Total Revenue, By Segment, 2010 2012 ($Million )     
Figure 71 Lexicon Pharmaceuticals : Strategy            
Figure 72 Mirimus : Geographic Presence             
Figure 73 Mirimus : Strategy             
Figure 74 Sage Labs : Geographic Presence           
Figure 75 Sage Labs : Strategy            
Figure 76 Taconic Farms : Geographic Presence           
Figure 77 Taconic Farms : Strategy             
Figure 78 The Jackson Laboratory : Geographic Presence          
Figure 79 The Jackson Laboratory : Total Revenue, 2010 2012 ($Million )     
Figure 80 The Jackson Laboratory : Total Revenue, By Segment, 2010 2012 ($Million )   
Figure 81 The Jackson Laboratory : Strategy           
Figure 82 Immunodeficient and Humanized Mouse Model Development Timeline         
Figure 83 Transgenic, Inc. : Geographic Presence           
Figure 84 Transgenic, Inc. : Strategy            
Figure 85 Colony Maintenance Types and Levels

Over the years, the use of mice models has increased rapidly. Mice have become the animals of choice for preclinical research in academic institutions as well as in pharmaceutical and biotechnology industries. The market has seen many innovations in the last few years, as companies have introduced new models for studying diseases like cancer and AIDS. The global market (models and services) is valued at $1,115.2 million in 2013 and is expected to reach $1,819.9 million by 2018, growing at a CAGR of 10.3% from 2013 to 2018.

This report categorizes the market into two broad segments, namely, mice models and services. By type, the market comprises of inbred, outbred, knockout, conditioned/surgically modified, hybrid/congenic, and spontaneous mutant mice. The inbred mice segment holds the largest share of 58% of the mice model market in 2013. This high share of inbred mice is attributed to their ability to reproduce the same results in different laboratories over a period of time.

The market for mice model services is segmented into breeding, cryopreservation, quarantine, rederivation, genetic testing, model in-licensing, and other services (surgical and line rescue). 

The breeding services market holds the largest share of the services market and is expected to grow at the highest CAGR of 15% from 2013 to 2018, to reach $521 million by 2018.

The mice care products market is categorized into cages, bedding, feed, and others. The caging market accounts for the largest share of the mice care products market, growing at a CAGR of 2.8% from 2013 to 2018 to reach $67.1 million in 2018.

High investments and grants, which are leading to rising innovations in mice models, is a key factor that is likely to drive the growth of this market. In addition, the increase in the number of R&D activities in pharmaceutical industries, which are the prime users of mice models, is also responsible for driving this market. Furthermore, the high genetic similarity between mice and humans is another factor that is driving the use of mice models, globally.

Mice Model Market by Geography, 2013

Mice Model Market

Source: MarketsandMarkets Analysis

The global market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America will continue to lead the mice model market in the forecast period, followed by Europe. Over the next five years, the growth of the mice model market in the Asian region is likely to be centered in China, India, Singapore, Malaysia, Taiwan, and Japan. This growth will be driven by factors such as the increasing number of research projects in Singapore and Korea and mandatory animal testing for all drugs and cosmetics in China.

The major players in the market include Charles River Laboratories (U.S.), The Jackson Laboratory (U.S.), Taconic farms, Inc. (U.S.), genOway S.A. (France), Covance, Inc. (U.S.), Crescendo Biologics Limited (U.K.), Deltagen, Inc. (U.S.), Harbour Antibodies BV (The Netherlands), Harlan Laboratories, Inc. (U.S.), TransGenic, Inc. (U.S.), SAGE Labs (U.S.), inGenious Targeting Laboratory, Inc. (U.S.), Lexicon Pharmaceuticals (U.S.), ImmunoGenes AG (Switzerland), Mirimus, Inc. (U.S.), and Ablexis LLC (U.S.).

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports